Top Track 250

Originally produced as durable boots for workers and later adopted by a variety of youth subcultures, Dr Martens’ iconic footwear and accessories now include luggage, clothing and children’s shoes. Backed by the private equity firm Permira, the Northamptonshire business drove ebitda profits up 70% to £85m on revenues of £454.4m in 2019, helped by market growth in Asia, America and Europe. Kenny Wilson, 53, joined from Cath Kidston last year as chief executive.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyDr Martens
ActivityShoe manufacturer and retailer
Sales £m*454.4
Operating profit £m*‡85.0
Main shareholders

Permira (70%), Griggs family and settlements (20%), management (10%)


If applicable:

* supplied by company   † annualised figure   ‡  profit = ebitda